People: Orthofix International NV (OFIX.OQ)

OFIX.OQ on NASDAQ Stock Exchange Global Select Market

32.13USD
17 Sep 2014
Price Change (% chg)

$1.02 (+3.28%)
Prev Close
$31.11
Open
$31.00
Day's High
$32.46
Day's Low
$31.00
Volume
33,884
Avg. Vol
39,043
52-wk High
$36.90
52-wk Low
$19.36

Search Stocks

Finegan, Michael 

Brief Biography

Mr. Michael M. Finegan has been appointed as Chief Strategy Officer of Orthofix International N.V., effective June 20, 2013. Mr. Finegan joined Orthofix in June 2006 as Vice President of Corporate Development, and became the President, Biologics in March 2009. In October 2011, he was promoted to Senior Vice President, Business Development, and President, Biologics. Prior to joining Orthofix, Mr. Finegan spent sixteen years as an executive with Boston Scientific in a number of different operating and strategic roles, most recently as Vice President of Corporate Sales. Earlier in his career, Mr. Finegan held sales and marketing roles with Marion Laboratories and spent three years in banking with First Union Corporation (Wachovia). Mr. Finegan earned a BA in Economics from Wake Forest University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
459,994 -- 175,000 1,043,370

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 35,000 854,708.00
Name Fiscal Year Total

Ronald Matricaria

--

Bradley Mason

3,013,200

Mark Heggestad

--

Davide Bianchi

892,787

Doug Rice

--

Jeffrey Schumm

1,038,360
As Of 30 Dec 2013
Search Stocks